Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Holdings Completes $4.8M Acquisition of A&B Aerospace, Expanding into Precision Manufacturing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.98
Mkt Cap
$8.412M
52W Low
$1.62
52W High
$309.12
52W Position info
22% above low
Off High info
99% below high
Rel. Volume
Market data snapshot near publication time

ELAB sits 22% above its 52-week low of $1.62.

Summary

PMGC Holdings Inc. has completed the acquisition of A&B Aerospace, Inc. for $4.8 million, significantly expanding its presence in precision aerospace and defense manufacturing as part of its roll-up strategy.


Key Events · M&A and Partnerships · ELAB

  • Acquisition Completed

    PMGC Holdings Inc. completed the acquisition of 100% of A&B Aerospace, Inc. on May 12, 2026.

  • Purchase Consideration

    The total consideration for the acquisition was $4.8 million in cash, including a $225,000 indemnification holdback.

  • Strategic Expansion

    This acquisition expands PMGC's presence in precision CNC machining for the aerospace and defense markets, aligning with its roll-up strategy.

  • Target Financials

    A&B Aerospace reported approximately $5.0 million in revenue and $610,000 in management-adjusted EBITDA for the trailing twelve months ended February 28, 2026.


Analysis · ELAB · Life Sciences

This acquisition is highly significant for PMGC Holdings, representing approximately 57% of its current market capitalization. It marks a substantial expansion into the precision aerospace and defense manufacturing sector, aligning with the company's stated roll-up strategy. For a company that recently received a going concern warning and has been actively raising capital through dilutive equity lines, successfully acquiring a profitable entity like A&B Aerospace (which reported $5.0M in revenue and $610K management-adjusted EBITDA) is a critical step towards building a sustainable business and addressing its financial challenges. The strategic fit with established blue-chip customers and high technical barriers to entry is a strong positive.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51.2% of the 201 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ELAB was trading at $1.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.4M. The 52-week trading range was $1.62 to $309.12. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ELAB - Latest Insights

ELAB
Nov 02, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.12
Real-time Price: $1.60 info
Change: -$0.5196 (-25%) info
Market Cap: $1.336M info
ELAB
Oct 01, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $3.62
Real-time Price: $1.60 info
Change: -$2.02 (-56%) info
Market Cap: $1.336M info
ELAB
Sep 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.70
Real-time Price: $1.60 info
Change: -$3.10 (-66%) info
Market Cap: $1.336M info
ELAB
Sep 02, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.20
Real-time Price: $1.60 info
Change: -$3.60 (-69%) info
Market Cap: $1.336M info
ELAB
Sep 01, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.23
Real-time Price: $1.60 info
Change: -$3.63 (-69%) info
Market Cap: $1.336M info